Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1999 1
2004 1
2006 2
2007 2
2008 1
2009 1
2010 4
2012 3
2013 2
2014 5
2015 4
2016 1
2017 3
2018 3
2019 5
2020 5
2021 2
2022 3
2023 2
2024 3
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

50 results

Results by year

Filters applied: . Clear all
Page 1
Capivasertib in Hormone Receptor-Positive Advanced Breast Cancer.
Turner NC, Oliveira M, Howell SJ, Dalenc F, Cortes J, Gomez Moreno HL, Hu X, Jhaveri K, Krivorotko P, Loibl S, Morales Murillo S, Okera M, Park YH, Sohn J, Toi M, Tokunaga E, Yousef S, Zhukova L, de Bruin EC, Grinsted L, Schiavon G, Foxley A, Rugo HS; CAPItello-291 Study Group. Turner NC, et al. N Engl J Med. 2023 Jun 1;388(22):2058-2070. doi: 10.1056/NEJMoa2214131. N Engl J Med. 2023. PMID: 37256976 Free PMC article. Clinical Trial.
Imlunestrant, an Oral Selective Estrogen Receptor Degrader, as Monotherapy and in Combination With Targeted Therapy in Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Phase Ia/Ib EMBER Study.
Jhaveri KL, Lim E, Jeselsohn R, Ma CX, Hamilton EP, Osborne C, Bhave M, Kaufman PA, Beck JT, Manso Sanchez L, Parajuli R, Wang HC, Tao JJ, Im SA, Harnden K, Yonemori K, Dhakal A, Neven P, Aftimos P, Pierga JY, Lu YS, Larson T, Jerez Y, Sideras K, Sohn J, Kim SB, Saura C, Bardia A, Sammons SL, Bacchion F, Li Y, Yuen E, Estrem ST, Rodrik-Outmezguine V, Nguyen B, Ismail-Khan R, Smyth L, Beeram M. Jhaveri KL, et al. Among authors: sideras k. J Clin Oncol. 2024 Dec 10;42(35):4173-4186. doi: 10.1200/JCO.23.02733. Epub 2024 Sep 6. J Clin Oncol. 2024. PMID: 39241211 Free PMC article. Clinical Trial.
Clinical Validity of Repeated Circulating Tumor Cell Enumeration as an Early Treatment Monitoring Tool for Metastatic Breast Cancer in the PREDICT Global Pooled Analysis.
Janni W, Friedl TWP, Yab TC, Bidard FC, Cristofanilli M, Hayes DF, Ignatiadis M, Regan MM, Alix-Panabieres C, Barlow WE, Caldas C, Carey LA, Dirix L, Fehm T, Garcia-Saenz JA, Gazzaniga P, Generali D, Gerratana L, Gisbert-Criado R, Jacot W, Jiang Z, Joosse SA, Lianidou E, López López R, Magbanua MJM, Manso L, Mavroudis D, Müller V, Munzone E, Pantel K, Pierga JY, Rack B, Riethdorf S, Rugo HS, Sideras K, Sleijfer S, Smerage J, Stebbing J, Terstappen LWMM, Vidal-Martínez J, Wallwiener M, Giridhar KV, Liu MC. Janni W, et al. Among authors: sideras k. Clin Cancer Res. 2025 Jun 3;31(11):2196-2209. doi: 10.1158/1078-0432.CCR-24-3108. Clin Cancer Res. 2025. PMID: 40100138 Free PMC article.
Amyloidosis.
Sideras K, Gertz MA. Sideras K, et al. Adv Clin Chem. 2009;47:1-44. Adv Clin Chem. 2009. PMID: 19634775 Review.
The impact of coadministration of venlafaxine, citalopram or gabapentin on the metabolic activation of tamoxifen.
Safgren SL, Suman VJ, Leon Ferre RA, Kosel ML, Stearns V, Henry NL, Denduluri N, Irvin W, Ingle JN, Sideras K, Ames MM, Reid JM, Loprinzi CL, Black JL, Weinshilboum RM, Goetz MP. Safgren SL, et al. Among authors: sideras k. Breast Cancer Res Treat. 2025 May;211(1):261-270. doi: 10.1007/s10549-025-07644-3. Epub 2025 Feb 27. Breast Cancer Res Treat. 2025. PMID: 40011368 Free PMC article.
Pembrolizumab in Combination with Binimetinib in Patients with Unresectable Locally Advanced or Metastatic Triple-Negative Breast Cancer.
Chumsri S, Larson JJ, Liu E, Tenner KS, Adams D, Weidner MT, Arnold AN, Haley DL, Advani P, Sideras K, Moreno-Aspitia A, Thompson EA, Perez EA, Knutson KL. Chumsri S, et al. Among authors: sideras k. Clin Cancer Res. 2025 May 15;31(10):1885-1893. doi: 10.1158/1078-0432.CCR-24-3001. Clin Cancer Res. 2025. PMID: 40053697 Free PMC article. Clinical Trial.
Anastrozole Dose Escalation for Optimal Estrogen Suppression in Postmenopausal Early-Stage Breast Cancer: A Prospective Trial.
Haddad TC, Suman VJ, Giridhar KV, Sideras K, Northfelt DW, Ernst BJ, O'Sullivan CC, Singh RJ, Desta Z, Peethambaram PP, Hobday TJ, Chumsri S, Leon-Ferre RA, Ruddy KJ, Yadav S, Taraba JL, Goodnature B, Goetz MP, Wang L, Ingle JN. Haddad TC, et al. Among authors: sideras k. Clin Cancer Res. 2024 Aug 1;30(15):3147-3156. doi: 10.1158/1078-0432.CCR-24-0341. Clin Cancer Res. 2024. PMID: 38752717 Free PMC article. Clinical Trial.
Coprescription of tamoxifen and medications that inhibit CYP2D6.
Sideras K, Ingle JN, Ames MM, Loprinzi CL, Mrazek DP, Black JL, Weinshilboum RM, Hawse JR, Spelsberg TC, Goetz MP. Sideras K, et al. J Clin Oncol. 2010 Jun 1;28(16):2768-76. doi: 10.1200/JCO.2009.23.8931. Epub 2010 May 3. J Clin Oncol. 2010. PMID: 20439629 Free PMC article. Review.
50 results